TOThomas Forland Oftedal

Thomas Forland Oftedal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thomas Forland Oftedal has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Novel insights into the biosynthesis and diversity of leaderless multipeptide bacteriocins

    by Thomas Førland Oftedal, Simen Hermansen, Even Amandus Haslund, Amar A. Telke, Tage Thorstensen, Kirill V. Ovchinnikov, Dzung B. Diep, Morten Kjos

    Garvicin KS (GarKS) is a three-peptide, leaderless, broad-spectrum bacteriocin that is active against a wide range of Gram-positive bacteria, including several foodborne pathogens and antibiotic-resistant strains. This bacteriocin is considered a candidate for application in food preservation and medical treatments; however, key knowledge about the producer strain, regulation of production, and the mechanism of action is still lacking for leaderless, multipeptide bacteriocins, including GarKS. A hybrid sequencing strategy was used to obtain a high-quality closed genome assembly of the native GarKS producer Lactococcus garvieae KS1546, which showed that the bacteriocin was encoded on a 50 kb plasmid (pKS50). Comparative analysis with updated sequence databases indicates that the producer strain should be reclassified as Lactococcus petauri . The roles of the biosynthetic genes, putatively encoding a transcriptional regulator ( gakR ) and immunity protein ( gakI ), were examined using heterologous expression. Removal of gakR resulted in a 6-fold decrease in GarKS production, and expression of gakI caused a 250-fold decrease in susceptibility to GarKS, with varying degrees of cross-immunity to other multipeptide bacteriocins. Isolation and whole-genome sequencing of spontaneous GarKS mutants in L. lactis showed that resistance levels are low, but that ythA , a PspC-domain-containing protein involved in a phage stress response pathway is involved in the GarKS susceptible phenotype. To decipher conserved features involved in production of these bacteriocins, we finally used genome mining to identify 11 candidates for new multipeptide bacteriocins; four of them were obtained synthetically and confirmed to be bioactive peptides inhibiting important pathogens including Listeria monocytogenes and enterococci.

  • Open Access

    The phage shock protein response of Listeria monocytogenes influences tolerance to the multipeptide bacteriocin garvicin KS

    by Thomas F. Oftedal, Trond Løvdal, Morten Kjos

    Food waste due to perishable and unsafe food products is a major issue worldwide. For some high-quality perishable food products, such as fresh fish and cold-smoked salmon, traditional food preservation techniques are unsuitable as they can compromise sensory qualities such as flavor, texture, and freshness. These products often support the growth of the human pathogen Listeria monocytogenes , which can be present if thermal treatment is not applied. Thus, antilisterial bacteriocins, such as garvicin KS (GarKS), in combination with other technologies like high-pressure processing, are being investigated as hurdle strategies to increase the shelf life and food safety of fish products. In this study, we aimed to identify potential resistance development and genetic factors affecting the susceptibility of L. monocytogenes towards GarKS. We show that L. monocytogenes strains associated with fish products and fish processing plants are susceptible to GarKS with MIC values ranging from 20 to 275 nM. By RNA sequencing, we showed that exposure to GarKS resulted in an upregulation of genes involved in the phage shock protein ( psp ) response. Furthermore, isolation of resistant mutants indicated a low frequency of resistance to GarKS (10⁻ 9 to 10⁻ 11 ). The GarKS-tolerant mutants isolated (2-fold increased MIC values) were shown to harbor disruption mutations in lmo2468 , encoding a PspC-domain-containing protein. Overexpression of this gene increased susceptibility to GarKS two-fold and restored wild-type susceptibility in a disruption mutant. This study thus demonstrates that resistance development to GarKS is rare and identifies the phage shock protein response as a key player involved in susceptibility to GarKS.


  • Open Access

    The bacteriocin enterocin EJ97s retains its antibacterial effect upon interaction with human serum albumin

    by Ingvild Reinseth, Krister Gjestvang Grønlien, Thomas Førland Oftedal, Morten Kjos, Harald Carlsen, Hanne H. Tønnesen

    Enterocin EJ97s is a bacteriocin with potent activity against vancomycin-resistant Enterococcus faecalis . Since EntEJ97 is active in the presence of blood and has been shown to circulate at therapeutic concentrations without causing damage in a murine model, it is considered a promising candidate for treatment of E. faecalis infections. The aim of this study was to investigate the interaction of EntEJ97s with human serum albumin (HSA) as a step in the pre-clinical assessment of this bacteriocin. The binding association between EntEJ97s and HSA was investigated with fluorescence, nano differential scanning calorimetry (nano DSC) and nano isothermal titration calorimetry (nano ITC). The results show low to moderate binding affinity between EntEJ97s and HSA, with a stoichiometry of less than one EntEJ97s per HSA molecule. Nano ITC competition experiments with competitive ligands indicated that the peptide binds to both the Sudlow I site and the Sudlow II site, the two main drug binding sites on HSA. Molecular modelling efforts corroborated the findings of a binding in the vicinity of these sites. The antibacterial effect of the peptide was preserved in the presence of physiological and experimental concentrations of HSA, as indicated by minimum inhibitory concentration experiments, and spot-on-lawn assays. These findings accentuate that the properties EntEJ97s has in association with HSA are favourable for intravenous treatment.

  • Open Access

    The phage shock protein response of Listeria monocytogenes influences tolerance to the multipeptide bacteriocin garvicin KS

    by Thomas F. Oftedal, Trond Løvdal, Morten Kjos

    An estimated 30% of all food produced worldwide is lost or wasted every year. A considerable portion of that waste is due to perishable food products, that spoil and can become unsafe to eat relatively quickly. For some high-quality perishables, such as fresh fish and cold-smoked salmon, traditional food preservation techniques are unsuitable as they can compromise sensory qualities such as flavor, texture, and freshness. These products often support the growth of the human pathogen Listeria monocytogenes , which can be present if thermal treatment is not applied. Thus, antilisterial bacteriocins like garvicin KS (GarKS) in combination with conventional technologies like high-pressure processing (HPP) or modified atmosphere packaging (MAP) are being investigated as hurdle strategies to increase the shelf life and food safety of packaged fish products. In this study we showed that L. monocytogenes strains associated with fish food and fish processing plants are susceptible to GarKS with MIC values ranging from 20 to 275 nM. Exposure to GarKS resulted in an upregulation of genes involved in the phage shock protein response, and isolation of resistant mutants indicated a low frequency of resistance to GarKS (10□□ to 10□ 11 ). Resistant mutants were shown to harbor disruption mutations in lmo2468 , encoding a PspC-domain-containing protein. Overexpression of this gene increased susceptibility to GarKS two-fold and restored wild-type susceptibility in a disruption mutant. This study identify the phage shock protein response as a key player involved in susceptibility to GarKS.

  • Open Access

    Transcriptomic response in planktonic and biofilm cells of S. mutans treated with sublethal concentrations of chlorhexidine

    by Sara Arbulu, Thomas F. Oftedal, Morten Kjos

    Chlorhexidine, an antimicrobial with a broad inhibitory spectrum, is commonly used to treat oral infections as an active ingredient in mouthwash. While typically used at high concentrations (1–2 mg/ml), oral bacteria can be exposed to sublethal concentrations due to the bioavailability and protective barrier of biofilms (dental plaques). Sublethal concentrations can cause transcriptional remodelling of bacteria such as Streptococcus mutans, a key player in dental caries. Using an RNA-seq approach, this report provides a compendium on the effect of sublethal concentrations of chlorhexidine on the transcriptome of S. mutans as planktonic cells and in biofilm states. S. mutans showed major transcriptional remodelling between planktonic and biofilm states. The transcriptional response towards chlorhexidine was more pronounced in planktonic cells compared to sessile cells. However, the response observed for biofilm-associated cells was not specific to chlorhexidine, as biofilms exposed to the β-lactam amoxicillin showed similar responses. Furthermore, we found that S. mutans modulates transcription of a multitude of ABC transporters both in planktonic and biofilm-associated cells upon exposure to these antimicrobials.

  • Open Access

    An antibiotic-free antimicrobial combination of bacteriocins and a peptidoglycan hydrolase: in vitro and in vivo assessment of its efficacy

    by Christian Kranjec, Thomas Forland Oftedal, Kirill V. Ovchinnikov, Vinicius da Silva Duarte, Simen Hermansen, Magdalena Kaus-Drobek, Izabela Sabała, Davide Porcellato, Harald Carlsen, Morten Kjos

    Mastitis is an inflammatory disease of the mammary gland commonly brought about by bac-terial pathogens that gain physical access to the glandular epithelium through the teat canal. In bovines, common mastitis-causing agents are environmental or pathogenic bacterial spe-cies, including staphylococci, streptococci, enterococci, and Gram-negative bacteria such as Escherichia coli . Current therapeutic strategies for bovine mastitis typically involve the ad-ministration of antibiotic formulations within the infected udder, possibly resulting in in-creased selection of antibiotic resistance and the accumulation of antibiotic residues within the milk. In this study, we sought to design an antibiotic-free antimicrobial formulation to treat bovine mastitis based on bacterial antimicrobial peptides (bacteriocins) and proteins (pepti-doglycan hydrolases). Using a combination of in vitro assays with a range of bacteriocins, we show that the combination of the thiopeptide micrococcin P1 (MP1) and the lantibiotic nisin A (NisA) is a robust antimicrobial formulation that effectively inhibits the growth of bo-vine mastitis-derived bacteria, both in planktonic and biofilm-associated growth modes. The addition of AuresinePlus (Aur, a staphylococcus-specific PGH) further increased the antimi-crobial potency against S. aureus . Furthermore, using two mouse models, a skin infection model and a mastitis model, we show that the combination MP1-NisA-Aur effectively inhibits methicillin-resistant S. aureus (MRSA) in vivo . We discuss the potential and challenges of using antibiotic-free antimicrobial combinations in the treatment of bacterial infections.


  • Open Access

    Design of Novel Saposin-like Bacteriocins Using a Hybrid Approach

    by Thomas F. Oftedal, Dzung B. Diep, Morten Kjos

    A multitude of approaches will be required to respond to the threat posed by the emergence and spread of antibiotic resistant pathogens. Bacteriocins have gained increasing attention as a possible alternative to antibiotics, as such peptide antimicrobials have mechanisms of action different from antibiotics and are therefore equally potent against antibiotic resistant bacteria as their susceptible counterparts. A group of bacteriocins known as saposin-like bacteriocins is believed to act directly on the bacterial membrane. Based on seven saposin-like leaderless bacteriocins, we have constructed a library of hybrid peptides containing all combinations of the N- and C-terminal halves of the native bacteriocins. All hybrid peptides were synthesized using in vitro protein expression and assayed for antimicrobial activity towards several pathogens. Of the 42 hybrid peptides, antimicrobial activity was confirmed for 11 novel hybrid peptides. Furthermore, several of the hybrid peptides exhibited altered antimicrobial spectra and apparent increase in potency compared to the peptides from which they were derived. The most promising hybrid, termed ISP26, was then obtained synthetically and shown to inhibit most of the Gram-positive species tested, including opportunistic pathogens and food spoilage bacteria. Additionally, ISP26 was shown to inhibit Acinetobacter, a species of Gram-negative bacteria frequently isolated from nosocomial infections. The activity of the hybrid library provides valuable insights into the design and screening of new active bacteriocins.


  • Open Access

    Design of Novel Saposin-like Bacteriocins Using a Hybrid Approach

    by Thomas Førland Oftedal, Dzung B. Diep, Morten Kjos

    A multitude of approaches will be required to respond to the threat posed by the emergence and spread of antibiotic resistant pathogens. Bacteriocins have gained increasing attention as a possible alternative to antibiotics, as such peptide antimicrobials have mechanisms of action different from antibiotics and are therefore equally potent against antibiotic resistant bacteria as their susceptible counterparts. A group of bacteriocins known as saposin-like bacteriocins are believed to act directly on the bacterial membrane. Based on seven saposin-like leaderless bacteriocins, we have constructed a library of hybrid peptides containing all combinations of the N- and C-terminal halves of the native bacteriocins. All hybrid peptides were synthesized using in vitro protein expression and assayed for antimicrobial activity towards several pathogens. Of the 42 hybrid peptides, antimicrobial activity was confirmed for 11 novel hybrid peptides. Furthermore, several of the hybrid peptides exhibited altered antimicrobial spectra and apparent increase in potency compared to the peptides from which they were derived. The most promising hybrid, termed ISP26, was then obtained synthetically and shown to inhibit most of the Gram-positive species tested, including opportunistic pathogens and food spoilage bacteria. Additionally, ISP26 was shown to inhibit Acinetobacter, a species of Gram-negative bacteria frequently isolated from nosocomial infections. The activity of the hybrid library provides valuable insights into the design and screening of new active bacteriocins.


  • Open Access

    Flow cytometric detection of vancomycin-resistant Enterococcus faecium in urine using fluorescently labelled enterocin K1

    by Thomas F. Oftedal, Dzung B. Diep

    A urinary tract infection (UTI) occurs when bacteria enter and multiply in the urinary system. The infection is most often caused by enteric bacteria that normally live in the gut, which include Enterococcus faecium. Without antibiotic treatment, UTIs can progress to life-threatening septic shock. Early diagnosis and identification of the pathogen will reduce antibiotic use and improve patient outcomes. In this work, we develop and optimize a cost-effective and rapid (< 40 min) method for detecting E. faecium in urine. The method uses a fluorescently labelled bacteriocin enterocin K1 (FITC-EntK1) that binds specifically to E. faecium and is then detected using a conventional flow cytometer. Using this detection assay, urine containing E. faecium was identified by an increase in the fluorescent signals by 25–73-fold (median fluorescence intensity) compared to control samples containing Escherichia coli or Staphylococcus aureus. The method presented in this work is a proof of concept showing the potential of bacteriocins to act as specific probes for the detection of specific bacteria, such as pathogens, in biological samples.


  • Open Access

    The extracellular domain of site-2-metalloprotease RseP is important for sensitivity to bacteriocin EntK1

    by Sofie S. Kristensen, Thomas F. Oftedal, Åsmund K. Røhr, Vincent G.H. Eijsink, Geir Mathiesen, Dzung B. Diep